CUD-CUD Study
Greenlighter
- Joined
- Apr 30, 2024
- Messages
- 3
Thomas here from the Cannabidiol (CBD) for Cannabis Use Disorder (CUD) Study at the University of Sydney.
Cannabis Use Disorder is long-term, persistent cannabis use despite significant harms related to your use, such as social and financial harms, e.g. spending more time or money on weed than you'd prefer.
I'm excited to announce that we are launching our Phase III clinical trial investigating a new treatment to help people aiming to reduce their cannabis use.
Study details
Ethics: ETH02467; ANZCTR: 12623000526673
The research team
I will be checking this thread and responding to any comments, so please post questions you may have .
Cannabis Use Disorder is long-term, persistent cannabis use despite significant harms related to your use, such as social and financial harms, e.g. spending more time or money on weed than you'd prefer.
I'm excited to announce that we are launching our Phase III clinical trial investigating a new treatment to help people aiming to reduce their cannabis use.
Study details
- A world first clinical trial for CUD, and the largest of its kind.
- A 12-week study involving study medication.
- 4 x research interviews at a research clinic located at your convenience.
- Reimbursement provided for your time.
- Our study is run across 5 sites in NSW and 2 sites in VIC.
- To learn more, click our Expression of Interest form; you can also contact us:
- Email: [email protected]
- Mobile: (+61) 431 519 459
Ethics: ETH02467; ANZCTR: 12623000526673
The research team
- Principal Investigator: Dr. Nicholas Lintzeris
- Clinical Trial Lead: Dr. Anjali Bhardwaj
- Database & Social Media Manager: Arshman (Arsh) Sahid
I will be checking this thread and responding to any comments, so please post questions you may have .